COMPOUNDS USE AS PHARMACEUTICALS

Brand Owner (click to sort) Address Description
ARASCO DSM IP ASSETS B.V. Het Overloon 1 Heerlen 6411TE Netherlands compounds for use as pharmaceuticals for lipid related disorders; nutritional additives and supplements and additives and supplements for infant formula;[ compounds for use in the manufacture of pharmaceuticals for lipid related disorders ];
DHASCO DSM IP ASSETS B.V. Het Overloon 1 Heerlen 6411TE Netherlands compounds for use as pharmaceuticals for lipid related disorders; nutritional additives and supplements and additives and supplements for infant formula;[ compounds for use in the manufacture of pharmaceuticals for lipid related disorders ];
EPASCO Martek Biosciences Corporation 6480 Dobbin Road Columbia MD 21045 compounds for use as pharmaceuticals for lipid related disorders; nutritional additives and supplements and additives and supplements for infant formula;compounds for use in the manufacture of pharmaceuticals for lipid related disorders;
 

Where the owner name is not linked, that owner no longer owns the brand

    
Technical Examples
  1. The present invention provides novel esterase proteins, Specifically, the present invention provides proteins having the same or substantially the same amino acid sequence as the amino acid sequence represented by SEQ ID NO: 1 or SEQ ID NO: 7, or salts thereof; their partial peptides or salts thereof: DNAs encoding the proteins; recombinant vectors containing the DNAs; transformants, a method of manufacturing the proteins; pharmaceuticals comprising the proteins or DNAs; antibodies to the proteins; a method of screening compounds or salts thereof having an activity of promoting the esterase activity of the proteins; the compounds obtained by the screening; and pharmaceuticals comprising the said compounds; etc.